Printer Friendly

Articles from M2 Pharma (June 15, 2015)

1-20 out of 20 article(s)
Title Author Type Words
3M/Ivera Medical, Catheter Connections Settle US Patent Infringement Litigation. 308
AbbVie updates Phase 1b, open-label, dose-escalation, international study of venetoclax combined with rituximab in CLL or SLL patients. 293
Agile Therapeutics wins US patent Twirla (ethinyl estradiol and levonorgestrel transdermal system. 216
ApiFix Device Reaches 50-Patient Milestone for Idiopathic Scoliosis Treatment. 113
Arcturus Therapeutics signs research collaboration and worldwide license agreement with Janssen Pharmaceuticals. 144
Cardiome Pharma announces intravenous vernakalant facilitates electrical cardioversion in patients with cardioversion resistant atrial fibrillation. 270
Ewers Named Interim CFO at Bovie Medical. 256
Glaukos Launches US IPO. 174
InSite Vision Incorporated completes New Drug Application for BromSite. 129
MEI Pharma updates Phase II study of Pracinostat in combination with azacitidine in elderly patients with newly diagnosed AML. 341
Men Put off Enlarged Prostate Treatment Due to Fear of Impotence, Ejaculation Problems, Finds Study. 419
Minehart Named as Clinical Advisor to Rivanna Medical. 216
NeuroMetrix Launches Wearable Pain Relief Technology Device. 172
OraSure secures USD10.4m HHS contract to advance rapid Ebola Test clinical development. 236
Spineguard Raises EUR 2.8m from Share Sale. 376
The Global Fund collaborates with Abbott. 164
The Medicines Patent Pool expands present licensing agreement with Gilead Sciences. 165
Tioga Pharmaceuticals starts Phase II clinical study of asimadoline. 195
US FDA Clears FH Ortho Orthopedic Arthrodesis Nail. 268
Zynex updates Q2 2015 revenue in USD3.2m to USD3.5m range. Financial report 240

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters